Endurant Capital Management as of March 31, 2020
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 51 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Sanofi-Aventis SA (SNY) | 8.1 | $18M | 410k | 43.72 | |
Pfizer (PFE) | 7.5 | $17M | 510k | 32.64 | |
Hologic (HOLX) | 7.5 | $17M | 474k | 35.10 | |
Si-bone (SIBN) | 7.2 | $16M | 1.3M | 11.95 | |
Oxford Immunotec Global | 7.1 | $16M | 1.7M | 9.26 | |
Cigna Corp (CI) | 5.7 | $13M | 71k | 177.19 | |
Anthem (ELV) | 4.5 | $9.8M | 43k | 227.03 | |
Zimmer Holdings (ZBH) | 4.3 | $9.5M | 94k | 101.08 | |
Evolent Health Inc bond | 4.2 | $9.3M | 11M | 0.83 | |
Zoetis Inc Cl A (ZTS) | 4.0 | $8.9M | 75k | 117.69 | |
Bristol Myers Squibb (BMY) | 3.5 | $7.6M | 137k | 55.74 | |
Becton, Dickinson and (BDX) | 3.2 | $7.1M | 31k | 229.77 | |
Johnson & Johnson (JNJ) | 2.9 | $6.4M | 49k | 131.14 | |
McKesson Corporation (MCK) | 2.2 | $4.9M | 36k | 135.26 | |
R1 Rcm | 2.0 | $4.4M | 485k | 9.09 | |
Encompass Health Corp (EHC) | 1.6 | $3.6M | 56k | 64.03 | |
Adapthealth Corp -a (AHCO) | 1.6 | $3.5M | 221k | 16.00 | |
Laboratory Corp. of America Holdings | 1.5 | $3.3M | 26k | 126.40 | |
Pra Health Sciences | 1.5 | $3.2M | 39k | 83.03 | |
Avantor (AVTR) | 1.4 | $3.1M | 249k | 12.49 | |
Prothena (PRTA) | 1.2 | $2.7M | 256k | 10.70 | |
Aclaris Therapeutics (ACRS) | 1.2 | $2.7M | 2.6M | 1.04 | |
Amgen (AMGN) | 1.2 | $2.7M | 13k | 202.76 | |
Hill-Rom Holdings | 1.2 | $2.6M | 26k | 100.61 | |
BioMarin Pharmaceutical (BMRN) | 1.1 | $2.4M | 29k | 84.51 | |
Takeda Pharmaceutical (TAK) | 1.1 | $2.4M | 156k | 15.18 | |
Centene Corporation (CNC) | 1.0 | $2.3M | 38k | 59.40 | |
DaVita (DVA) | 0.9 | $2.1M | 27k | 76.06 | |
Dentsply Sirona (XRAY) | 0.9 | $2.0M | 53k | 38.83 | |
Trillium Therapeutics, Inc. Cmn | 0.9 | $1.9M | 478k | 4.04 | |
Charles River Laboratories (CRL) | 0.8 | $1.7M | 13k | 126.19 | |
Senseonics Hldgs Inc note 5.250% 2/0 | 0.7 | $1.5M | 1.5M | 0.99 | |
Gw Pharmaceuticals Plc ads | 0.7 | $1.5M | 17k | 87.57 | |
Zogenix | 0.7 | $1.5M | 59k | 24.73 | |
Insmed (INSM) | 0.5 | $1.2M | 74k | 16.03 | |
AtriCure (ATRC) | 0.5 | $1.1M | 34k | 33.60 | |
Fate Therapeutics (FATE) | 0.4 | $905k | 41k | 22.22 | |
Iqvia Holdings (IQV) | 0.4 | $899k | 8.3k | 107.90 | |
Axsome Therapeutics (AXSM) | 0.3 | $728k | 12k | 58.87 | |
Flamel Technologies Sa | 0.3 | $696k | 88k | 7.94 | |
Selecta Biosciences | 0.3 | $615k | 255k | 2.41 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $605k | 20k | 29.94 | |
D Fluidigm Corp Del (LAB) | 0.3 | $590k | 232k | 2.54 | |
Principia Biopharma | 0.2 | $530k | 8.9k | 59.37 | |
Macrogenics (MGNX) | 0.2 | $510k | 88k | 5.82 | |
Hca Holdings (HCA) | 0.2 | $509k | 5.7k | 89.83 | |
Genocea Biosciences (GNCAQ) | 0.2 | $455k | 264k | 1.72 | |
Adaptimmune Therapeutics (ADAP) | 0.2 | $435k | 160k | 2.72 | |
Ovid Therapeutics (OVID) | 0.2 | $347k | 116k | 2.98 | |
PetMed Express (PETS) | 0.1 | $287k | 10k | 28.80 | |
Kadmon Hldgs | 0.1 | $256k | 61k | 4.18 |